Development of Nephrotic Syndrome in a Patient with Rheumatoid Arthritis Treated with Certolizumab

REFERENCES

1. 1.↵
   1. Caporali R,
   2. Pallavicini FB,
   3. Filippini M,
   4. Gorla R,
   5. Marchesoni A,
   6. Favalli EG,
   7. et al.

   Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal. Autoimmun Rev 2009;8:274–80.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. McInnes IB,
   2. Schett G

   . The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205–19.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Piga M,
   2. Chessa E,
   3. Ibba V,
   4. Mura V,
   5. Floris A,
   6. Cauli A,
   7. et al.

   Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: systematic literature review and analysis of a monocentric cohort. Autoimmun Rev 2014;13:873–9.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Perez-Alvarez R,
   2. Perez-de-Lis M,
   3. Ramos-Casals M

   . Biologics-induced autoimmune diseases. Curr Opin Rheumatol 2013;25:56–64.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Leong J,
   2. Fung-Liu B

   . A case report of nephrotic syndrome due to intake of certolizumab pegol in a patient with Crohn’s disease. Am J Gastroenterol 2010;105:234.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Kronbichler A,
   2. Mayer G

   . Renal involvement in autoimmune connective tissue diseases. BMC Med 2013;11:95.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Helin HJ,
   2. Korpela MM,
   3. Mustonen JT,
   4. Pasternack AI

   . Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum 1995;38:242–7.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Maruotti N,
   2. Corrado A,
   3. Gaudio A,
   4. Cantatore FP

   . Membranous nephropathy in rheumatoid arthritis: a case report. Clin Exp Rheumatol 2009;27:840–2.

   OpenUrlPubMed